A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma

被引：0
|
作者：
Oladapo Yeku
Andrea L. Russo
Hang Lee
David Spriggs
机构：
[1] Harvard Medical School,Division of Hematology
[2] Massachusetts General Hospital,Oncology, Department of Medicine
[3] Harvard Medical School,Department of Radiation Oncology
[4] Massachusetts General Hospital,Biostatistics Center
[5] Harvard Medical School,undefined
[6] Massachusetts General Hospital,undefined
来源：
Journal of Translational Medicine | / 18卷
关键词：
Vulvar cancer; Pembrolizumab; Chemoradiation; Immunotherapy; Chemoimmunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma
    Yeku, Oladapo
    Russo, Andrea L.
    Lee, Hang
    Spriggs, David
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [2] A topical chemo-immunotherapy for squamous cell carcinoma
    Friedman, Blake
    Donahue, Cara
    Erdos, Geza
    Falo, Louis D.
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [3] Combination chemo-immunotherapy in advanced oesophageal squamous cell carcinoma
    Sjoquist, Katrin Marie
    LANCET ONCOLOGY, 2023, 24 (05): : 419 - 420
  • [4] Chemo-immunotherapy in advanced esophageal squamous cell carcinoma: present and future
    Zi-Xian Wang
    Rui-Hua Xu
    Holistic Integrative Oncology, 2 (1):
  • [5] A microneedle array patch chemo-immunotherapy for cutaneous squamous cell carcinoma
    Yang, Yufan
    Zhang, Haotong
    Carey, Cara D.
    Zhang, Jiying
    Balmert, Stephen C.
    Korkmaz, Emrullah
    Falo, Louis D.
    CANCER RESEARCH, 2024, 84 (06)
  • [6] COMBINED CHEMO-IMMUNOTHERAPY AND RADIATION-THERAPY OF INFLAMMATORY BREAST-CARCINOMA
    KRUTCHIK, AN
    BUZDAR, AU
    BLUMENSCHEIN, GR
    HORTOBAGYI, GN
    TASHIMA, CK
    GUTTERMAN, JU
    YAP, HY
    HERSH, EM
    JOURNAL OF SURGICAL ONCOLOGY, 1979, 11 (04) : 325 - 332
  • [7] Multicenter phase II study of chemo-immunotherapy in the treatment of metastatic renal cell carcinoma
    Recchia, Francesco
    Saggio, Gaetano
    Amiconi, Giovanna
    Di Blasio, Anna
    Cesta, Alisia
    Candeloro, Giampiero
    Necozione, Stefano
    Fumagalli, Luca
    Rea, Silvio
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (04) : 448 - 454
  • [8] Pembrolizumab for vulvar squamous cell carcinoma: results from the phase 2 KEYNOTE-158 study
    Frommer, Ronnie Shapira
    Mileshkin, Linda
    Manzyuk, Ludmila
    Penel, Nicolas
    Burge, Matthew
    Piha-Paul, Sarina
    Girda, Eugenia
    Martin, Jose Lopez
    van Dongen, Marloes
    Italiano, Antoine
    Xu, Lei
    Jin, Fan
    Norwood, Kevin
    Ott, Patrick
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S44 - S44
  • [9] Paclitaxel combined with fractionated radiation in vitro:: A study with vulvar squamous cell carcinoma cell lines
    Raitanen, M
    Rantanen, V
    Kulmala, J
    Pulkkinen, J
    Klemi, P
    Grénman, S
    Grénman, R
    INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (06) : 853 - 857
  • [10] Neoadjuvant chemo-immunotherapy versus neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    Wang, X.
    Fang, M.
    Jiang, Y.
    Tao, K.
    Ji, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S165 - S165
12345